Welcome to our dedicated page for Cross Ctry Healthcare SEC filings (Ticker: CCRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cross Country Healthcare filings document the regulatory record for a Nasdaq-listed healthcare workforce solutions company with common stock registered under CCRN. Its SEC reports include Form 8-K disclosures for operating and financial results, Regulation FD communications, material agreements, executive appointments and departures, compensation arrangements and other governance matters.
Proxy and shareholder materials describe director elections, voting matters, executive compensation, board governance and capital-structure information. The filing record also covers the company’s staffing, recruitment, advisory and Intellify platform activities through business updates and financial disclosures tied to healthcare labor markets and technology-enabled workforce management.
CROSS COUNTRY HEALTHCARE INC Chief Human Resources Officer Colin Patrick McDonald sold 6,200 shares of common stock in an open-market transaction on March 11, 2026 at a weighted average price of about $9.70 per share. After this sale, he directly holds 28,060 shares of the company’s common stock.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice proposing the sale of 6,200 shares of Common Stock (listed on NASDAQ), dated 03/11/2026. The notice breaks the position into three grant types: 3,046 performance shares (03/31/2023), 1,117 restricted stock (03/31/2023), and 2,037 performance shares (03/31/2024).
Cross Country Healthcare, Inc. announced leadership changes in its finance and technology functions. Effective March 10, 2026, James V. Redd III will step down as Senior Vice President and Chief Accounting Officer, and Phil Noe will step down as Chief Information Officer. The company states that neither departure results from any dispute or disagreement, including on accounting practices or financial reporting.
The Board appointed longtime employee Marvin Veizaga as Senior Vice President and Chief Accounting Officer, effective the same date. Veizaga has been with the company since 2015 in increasingly senior controller roles and previously worked as a Senior Auditor at Deloitte & Touche LLP. Under a new Letter Agreement, his base salary will be $340,000, with an annual short-term incentive bonus target of 50% of base salary and an annual long-term equity incentive target of 50% of base salary. The company notes there are no related-party arrangements or family relationships tied to his appointment.
Cross Country Healthcare, Inc. filed its annual report describing its AI‑driven healthcare staffing and workforce solutions business across nursing, allied, physician, education, and PACE programs in all 50 U.S. states. The company notes that Aya Holdings terminated a planned merger and paid a $20.0 million cash termination fee.
Following the deal’s end, co‑founder and Chairman Kevin C. Clark was appointed President and CEO, succeeding John A. Martins. The filing highlights ongoing investments in the Intellify® SaaS platform, AI and automation, and a largely remote, U.S.–India operating model, while detailing extensive risk factors including technology, cybersecurity, regulatory, litigation, and labor market pressures.
Cross Country Healthcare reported sharply weaker results for Q4 and full year 2025 as demand for healthcare staffing continued to soften and merger-related impacts weighed on earnings. Fourth quarter revenue was $236.8 million, down 24% from a year ago and 5% from the prior quarter, while full-year revenue fell 22% to $1.05 billion.
Profitability deteriorated significantly. Q4 net loss attributable to common stockholders widened to $82.9 million, and the full-year net loss reached $94.9 million, or $2.93 per diluted share. Results were heavily affected by a $77.9 million non-cash impairment of goodwill and trade names and a $29.6 million valuation allowance against deferred tax assets, both tied to a decline in the company’s market value after the Aya merger agreement was terminated.
On an adjusted basis, Q4 EBITDA was $4.1 million, or 1.7% of revenue, down from $9.3 million and a 3.0% margin a year earlier. Full-year adjusted EBITDA dropped to $26.8 million, or a 2.5% margin, from $49.1 million and 3.7%. Management’s outlook for Q1 2026 calls for revenue of $235 million to $240 million and adjusted EBITDA of $4.0 million to $5.0 million, implying revenue declines of roughly 18% to 20% year-over-year and substantially lower adjusted earnings.
Cross Country Healthcare, Inc. is providing an update on investor outreach activities. The company announced it is scheduled to participate in the Truist Securities Virtual Human Capital Conference on March 12–13, 2026 and the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16–19, 2026.
At both events, executives including Executive Vice President & Chief Financial Officer William J. Burns and Vice President of Investor Relations Josh Vogel will hold one-on-one meetings with investors, with no formal presentations planned.
CROSS COUNTRY HEALTHCARE INC executive Amiee Lin Hawkins filed an initial ownership report on Form 3. She reported direct ownership of 29,273 shares of the company’s common stock, reflecting her existing stake as Chief Solutions & Operations Officer, with no specific buy or sell transactions disclosed.
AllianceBernstein L.P. filed Amendment No. 2 to a Schedule 13G/A reporting its beneficial ownership of Cross Country Healthcare Inc. common stock. As of 12/31/2025, AllianceBernstein reported beneficial ownership of 31,215 shares, representing 0.1% of the outstanding common stock.
The shares are held solely for investment purposes in client discretionary investment advisory accounts, with AllianceBernstein having sole voting and dispositive power over these shares and no shared power. The filing states the holdings are in the ordinary course of business and not for changing or influencing control of Cross Country Healthcare.
Cross Country Healthcare, Inc. is informing investors about its upcoming fourth quarter and full year 2025 earnings conference call. The call will take place on Wednesday, March 4, 2026 at 5:00 p.m. Eastern Time, with an earnings press release expected after market close that day.
The call will be accessible via live webcast on the company’s investor relations website at ir.crosscountry.com and by phone using listed U.S. and international dial-in numbers with the passcode “Cross Country.” A replay will be available online and by telephone from March 4 through March 18.
The filing presents this information under a Regulation FD disclosure item and includes a furnished press release as an exhibit, outlining the call logistics and offering a brief description of Cross Country Healthcare’s technology-driven healthcare workforce solutions business.
Cross Country Healthcare, Inc. has set May 11, 2026 as the date for its virtual-only 2026 Annual Meeting of Stockholders. Details on the meeting time and website will appear in the proxy statement, which is expected to be made available on or about March 31, 2026.
Stockholder proposals for inclusion in the proxy statement under Rule 14a-8 must reach the company’s principal executive office by the close of business on March 11, 2026. Under the company’s bylaws, notices to propose other business or nominate directors must be delivered by February 10, 2026.
To use the universal proxy rules for director nominees other than the company’s, stockholders must provide the information required by Rule 14a-19 by March 12, 2026. All materials are to be sent to the Corporate Secretary at the Boca Raton, Florida headquarters.